Curebase optimizes patient retention rates in CNS studies by implementing validated engagement tactics.

lorem ipsum

Get the case study

In Curebase’s first international study, Quit Genius, a leading addiction digital clinic based in the United Kingdom was looking to test the preliminary effectiveness of a novel digital therapeutic intervention for smoking cessation. This treatment tool consisted of a digital therapeutic intervention via a smartphone app that delivered cognitive behavioral therapy, one-on-one coaching, craving tools, and more. In order to collect the necessary data over specific periods of time, Quit Genius enlisted Curebase’s decentralized clinical trial model.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
548 Market St
PMB 86319
San Francisco, CA 94104-5401
United States